Thinking about the case...
The FORTIS transcatheter mitral valve, developed by Edwards Lifesciences, is a self-expanding device currently undergoing first-in-man trials and implanted via a transapical approach. This research article presents the latest evidence on the innovative mitral valve intervention technique.
The FORTIS transcatheter mitral valve (Edwards Lifesciences, Irvine, CA, USA) is a self-expanding device implanted via a transapical approach that is currently undergoing first-in-man trials. Below is a link to the paper with the latest evidence on the device and a link to the news release.
Bapat et al. 2014 Eurointervention
Dr. Peter Hansen presents a comprehensive overview of transcatheter mitral valve therapies, highlig…
This presentation by Prof Greg Scalia explores the critical considerations for surgical and transca…
This research update presents recent seminal papers across cardiology, cardiac surgery, cardiac ima…
This research article reviews contemporary percutaneous approaches to mitral valve repair, specific…